{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:44:17Z","timestamp":1792799057405,"version":"4.5.0"},"reference-count":32,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"unspecified","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Central Plains Science and Technology Innovation Leading Talents","award":["264200510035"],"award-info":[{"award-number":["264200510035"]}]},{"name":"the National Key Research and Development Program of China","award":["2019YFC1316101"],"award-info":[{"award-number":["2019YFC1316101"]}]},{"name":"Joint Fund for Science and Technology Research and Development of Henan province","award":["242301420013"],"award-info":[{"award-number":["242301420013"]}]},{"name":"the National Natural Science Foundation of China","award":["81872486"],"award-info":[{"award-number":["81872486"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Natural Science Foundation of China","award":["82573507"],"award-info":[{"award-number":["82573507"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Shanghai Pujiang Program","award":["24PJA139"],"award-info":[{"award-number":["24PJA139"]}]},{"name":"the Strategic Priority Research Program of the Chinese Academy of Science","award":["XDB0990303"],"award-info":[{"award-number":["XDB0990303"]}],"id":[{"id":"https:\/\/ror.org\/034t30j35","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Henan Province for Distinguished Young Scholars","award":["252300421025"],"award-info":[{"award-number":["252300421025"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,9,10]]},"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1136\/jitc-2026-016326","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:05:26Z","timestamp":1790615126000},"page":"e016326","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["IL-23-engineered oncolytic vaccinia virus enhances pancreatic cancer control through inflammasome-driven Th17-skewed CD4\n                    <sup>+<\/sup>\n                    T-cell responses"],"prefix":"10.1136","volume":"14","author":[{"given":"Yu","family":"Guo","sequence":"first","affiliation":[{"name":"Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Basic Medical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Xuan","sequence":"additional","affiliation":[{"name":"Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Basic Medical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvla","family":"Pan","sequence":"additional","affiliation":[{"name":"Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Basic Medical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6641-667X","authenticated-orcid":false,"given":"Wenyi","family":"Yan","sequence":"additional","affiliation":[{"name":"Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Basic Medical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China"},{"name":"Henan Red Cross Blood Centre, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisiyu","family":"Cheng","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Xu","sequence":"additional","affiliation":[{"name":"Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Basic Medical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlei","family":"Sun","sequence":"additional","affiliation":[{"name":"Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Basic Medical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxia","family":"Han","sequence":"additional","affiliation":[{"name":"Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Basic Medical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Si","sequence":"additional","affiliation":[{"name":"Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Basic Medical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2367-6313","authenticated-orcid":false,"given":"Yaohe","family":"Wang","sequence":"additional","affiliation":[{"name":"Centre for Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-3902","authenticated-orcid":false,"given":"Pengju","family":"Wang","sequence":"additional","affiliation":[{"name":"Sino-British Research Centre for Molecular Oncology, National Centre for International Research in Cell and Gene Therapy, State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, School of Basic Medical Sciences, School of Convergence Medicine, Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"2026102102201136000_14.9.e016326.1","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic virotherapy: basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026102102201136000_14.9.e016326.2","doi-asserted-by":"crossref","first-page":"217389","DOI":"10.1016\/j.canlet.2024.217389","article-title":"H19 promotes polarization and alternative splicing in tumor-associated macrophages, facilitating pancreatic cancer progression","volume":"611","author":"Liu","year":"2025","journal-title":"Cancer Lett"},{"key":"2026102102201136000_14.9.e016326.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09416-2"},{"key":"2026102102201136000_14.9.e016326.4","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010341","article-title":"Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine pancreatic cancer","volume":"13","author":"Jia","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026102102201136000_14.9.e016326.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05254-3"},{"key":"2026102102201136000_14.9.e016326.6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00539","article-title":"Danger signals and graft-versus-host disease: current understanding and future perspectives","volume":"7","author":"Toubai","year":"2016","journal-title":"Front Immunol"},{"key":"2026102102201136000_14.9.e016326.7","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2287"},{"key":"2026102102201136000_14.9.e016326.8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1331217","article-title":"IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy","volume":"15","author":"Krueger","year":"2024","journal-title":"Front Immunol"},{"key":"2026102102201136000_14.9.e016326.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0398-2"},{"key":"2026102102201136000_14.9.e016326.10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9143","article-title":"Durable anticancer immunity from intratumoral administration of IL-23, IL-36\u03b3, and OX40L mRNAs","volume":"11","author":"Hewitt","year":"2019","journal-title":"Sci Transl Med"},{"key":"2026102102201136000_14.9.e016326.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01755-7"},{"key":"2026102102201136000_14.9.e016326.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0928-6"},{"key":"2026102102201136000_14.9.e016326.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb07554.x"},{"key":"2026102102201136000_14.9.e016326.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.09.013"},{"key":"2026102102201136000_14.9.e016326.15","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101640","article-title":"Pan-cancer mapping of single CD8+ T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity","volume":"5","author":"Tooley","year":"2024","journal-title":"Cell Rep Med"},{"key":"2026102102201136000_14.9.e016326.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.07.015"},{"key":"2026102102201136000_14.9.e016326.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02371-y"},{"key":"2026102102201136000_14.9.e016326.18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.11.5448"},{"key":"2026102102201136000_14.9.e016326.19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003329","article-title":"CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer","volume":"9","author":"Muthuswamy","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026102102201136000_14.9.e016326.20","doi-asserted-by":"crossref","unstructured":"Wang B , Wang Y , Sun X , et al . CXCR6 is required for antitumor efficacy of intratumoral CD8(+) T cell. J Immunother Cancer 2021;9. doi:10.1136\/jitc-2021-003100","DOI":"10.1136\/jitc-2021-003100"},{"key":"2026102102201136000_14.9.e016326.21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1022136","article-title":"CXCR6 expressing T cells: Functions and role in the control of tumors","volume":"13","author":"Mabrouk","year":"2022","journal-title":"Front Immunol"},{"key":"2026102102201136000_14.9.e016326.22","doi-asserted-by":"publisher","DOI":"10.1038\/nature04808"},{"key":"2026102102201136000_14.9.e016326.23","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.7150\/thno.56494","article-title":"Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"2026102102201136000_14.9.e016326.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112128"},{"key":"2026102102201136000_14.9.e016326.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.02.044"},{"key":"2026102102201136000_14.9.e016326.26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"2026102102201136000_14.9.e016326.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15229-5"},{"key":"2026102102201136000_14.9.e016326.28","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2009.74"},{"key":"2026102102201136000_14.9.e016326.29","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-024-07487-W"},{"key":"2026102102201136000_14.9.e016326.30","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty560"},{"key":"2026102102201136000_14.9.e016326.31","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3317"},{"key":"2026102102201136000_14.9.e016326.32","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3122"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-016326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:20:19Z","timestamp":1792574419000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-016326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,28]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/jitc-2026-016326"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-016326","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}